Literature DB >> 6953446

Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man.

T S Parker, D J McNamara, C Brown, O Garrigan, R Kolb, H Batwin, E H Ahrens.   

Abstract

We tested the hypothesis that the rate of cholesterol synthesis in tissues determines the concentrations of mevalonic acid (MVA) in plasma. We found that plasma MVA concentrations were correlated (i) with increased rates of whole-body cholesterol synthesis (measured by sterol-balance methods) in patients treated with cholestryamine resin (ii) with decreased rates of whole-body sterol synthesis (indicated by conversion of labeled acetate to sterol in freshly isolated mononuclear leukocytes) in out-patients after 4 weeks on a cholesterol-rich diet. In addition, a diurnal rhythm of plasma MVA concentrations was observed in patients whose activities were strictly controlled on a metabolic ward. At the peak of the rhythm (between midnight and 3 a.m.) MVA concentrations were 3-5 times greater than at the nadir (between 9 a.m. and noon). Furthermore, a relationship between the diurnal rhythm of plasma MVA and endogenous cholesterol synthesis is suggested by our finding that the plasma MVA rhythm was suppressed by cholesterol feeding (1,200 mg/day) and abolished by a 12-day fast. The presence in human plasma of MVA, an obligate precursor of cholesterol, in amounts apparent related to the rate of cholesterol synthesis offers a noninvasive, nonisotopic method for studying cholesterol synthesis in man.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6953446      PMCID: PMC346344          DOI: 10.1073/pnas.79.9.3037

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Interconversion of active and inactive forms of rat liver hydroxymethylglutaryl-CoA reductase.

Authors:  J L Nordstrom; V W Rodwell; J J Mitschelen
Journal:  J Biol Chem       Date:  1977-12-25       Impact factor: 5.157

2.  Blood concentration and turnover of circulating mevalonate in the rat.

Authors:  L Hagenfeldt; K Hellström
Journal:  Life Sci II       Date:  1972-07-08

3.  Fine structure of the cyclic rhythm of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Differential effects of cholesterol feeding and fasting.

Authors:  D J Shapiro; V W Rodwell
Journal:  Biochemistry       Date:  1972-03-14       Impact factor: 3.162

4.  Serum squalene and methyl sterols as indicators of cholesterol synthesis in vivo.

Authors:  T A Miettinen
Journal:  Life Sci       Date:  1969-07-15       Impact factor: 5.037

5.  Changes in cholesterol synthesis and excretion when cholesterol intake is increased.

Authors:  P J Nestel; A Poyser
Journal:  Metabolism       Date:  1976-12       Impact factor: 8.694

6.  Regulation of rat liver beta-hydroxy-beta-methylglutaryl-CoA reductase activity by cholesterol.

Authors:  M Higgins; H Rudney
Journal:  Nat New Biol       Date:  1973-11-14

7.  Effects of dietary cholesterol on the regulation of total body cholesterol in man.

Authors:  E Quintão; S M Grundy; E H Ahrens
Journal:  J Lipid Res       Date:  1971-03       Impact factor: 5.922

8.  New micromethod for measuring cholesterol in plasma lipoprotein fractions.

Authors:  T J Bronzert; H B Brewer
Journal:  Clin Chem       Date:  1977-11       Impact factor: 8.327

9.  The interaction of cholesterol absorption and cholesterol synthesis in man.

Authors:  S M Grundy; E H Ahrens; J Davignon
Journal:  J Lipid Res       Date:  1969-05       Impact factor: 5.922

10.  Measurement of cholesterol synthesis in man by isotope kinetics of squalene.

Authors:  G C Liu; E H Ahrens; P H Schreibman; P Samuel; D J McNamara; J R Crouse
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

View more
  29 in total

1.  Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women.

Authors:  N R Matthan; M Raeini-Sarjaz; A H Lichtenstein; L M Ausman; P J Jones
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

2.  Statin Dosing Instructions, Medication Adherence, and Low-Density Lipoprotein Cholesterol: a Cohort Study of Incident Statin Users.

Authors:  Zachary A Marcum; Hsiao-Ching Huang; Robert J Romanelli
Journal:  J Gen Intern Med       Date:  2019-07-31       Impact factor: 5.128

3.  Circadian variations in rat liver gene expression: relationships to drug actions.

Authors:  Richard R Almon; Eric Yang; William Lai; Ioannis P Androulakis; Debra C DuBois; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2008-06-18       Impact factor: 4.030

4.  Short-term effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor on cholesterol and bile acid synthesis in humans.

Authors:  T Yoshida; A Honda; J Shoda; M Abei; Y Matsuzaki; N Tanaka; H Miyazaki; T Osuga
Journal:  Lipids       Date:  1997-08       Impact factor: 1.880

Review 5.  Treatment of hypercholesterolemia in black patients.

Authors:  J T Wright; J M McKenney; A J Wasserman
Journal:  J Natl Med Assoc       Date:  1988-09       Impact factor: 1.798

Review 6.  Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Authors:  Pertti J Neuvonen; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys.

Authors:  D J McNamara; E H Ahrens; T S Parker; K Morrissey
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Low dose of ROSuvastatin in combination with EZEtimibe effectively and permanently reduce low density lipoprotein cholesterol concentration independently of timing of administration (ROSEZE): A randomized, crossover study - preliminary results.

Authors:  Karolina Obońska; Michał Kasprzak; Kamila Tymosiak; Tomasz Fabiszak; Magdalena Krintus; Jacek Kubica
Journal:  Cardiol J       Date:  2020-11-17       Impact factor: 2.737

9.  Diurnal variation of plasma methyl sterols and cholesterol in the rat: relation to hepatic cholesterol synthesis.

Authors:  T E Strandberg; R S Tilvis; T A Miettinen
Journal:  Lipids       Date:  1984-03       Impact factor: 1.880

10.  Determination of key intermediates in cholesterol and bile acid biosynthesis by stable isotope dilution mass spectrometry.

Authors:  Tadashi Yoshida; Akira Honda; Hiroshi Miyazaki; Yasushi Matsuzaki
Journal:  Anal Chem Insights       Date:  2008-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.